ACRIBiS - Advancing Cardiovascular Risk Identification with Structured Clinical Documentation and Biosignal Derived Phenotypes Synthesis"


Duration of the project: April 2023 - March 2027


ACRIBiS, a BMBF-funded medical informatics consortium with 15 research institutions, aims to improve the implementation of personalized risk assessment tools (PRT) in the clinical routine of cardiovascular medicine in Germany. By combining structured clinical recordings with high-resolution biosignal analysis, the predictive performance of these instruments is to be evaluated and optimized in practice. Standardized routine clinical documentation will be established and an interoperable infrastructure created. The aim is to develop effective and dynamically adaptable clinical decision support in order to better take into account the individual needs of patients and improve the quality of care.




Latest News

SBHD 2024

Our colleaugues at Vanderbilt University organise the 16th INTERNATIONAL CONFERENCE ON SYSTEMS BIOLOGY OF HUMAN DISEASE – SBHD 2024 this year from June 10-12. Don’t miss the opportunity to

Top 100 Köpfe der Wissenschaft 2023

Am 11.10.2023 wurde Prof. Roland Eils im Tagesspiegel als einer der 100 wichtigsten Köpfe der Hauptstadt-Wissenschaft gewürdigt. So schreibt der Tagesspiegel: "Um Big Data dreht sich alles in der

Young BIH scientists attend 72nd Lindau Nobel Laureate Meeting

The Lindau Nobel Laureate Meetings are annual conferences where some of the brightest minds in science converge to exchange knowledge, foster collaboration, and inspire the next generation of

Roland Eils wird als Highly Cited Researcher international gelistet.

Roland Eils gehört zu den weltweit am häufigsten zitierten Forschenden des Jahres 2022, wie aus der Liste der „Highly Cited Researchers“ hervorgeht, die das Unternehmen Clarivate heute veröffentlicht